Skip to main content
YUNGJIN PHARM. CO., LTD logo

YUNGJIN PHARM. CO., LTD — Investor Relations & Filings

Ticker · 003520 ISIN · KR7003520004 KO Manufacturing
Open in API
Filings indexed 193 across all filing types
Latest filing 2022-05-30 Major Shareholding Noti…
Country KR South Korea
Listing KO 003520

About YUNGJIN PHARM. CO., LTD

https://eng.yungjin.co.kr/

Yungjin Pharm. Co., Ltd. is a pharmaceutical company engaged in the research, development, manufacturing, and sale of pharmaceutical products for domestic and international markets. The company's portfolio includes a range of prescription drugs, with a focus on areas such as cephalosporin antibiotics and antipsychotic medications. Yungjin Pharm is actively involved in advancing its R&D pipeline, which includes collaborative research for treatments of rare conditions like mitochondrial diseases. Leveraging extensive drug production expertise and R&D capabilities, the company operates as a key affiliate within the KT&G Group's bio/pharmaceutical business.

Recent filings

Filing Released Lang Actions
대규모기업집단현황공시[연1회공시및1/4분기용(개별회사)]
Major Shareholding Notification Classification · 100% confidence The document is a 'Corporate Group Status Disclosure' (기업집단현황공시) for Youngjin Pharm, a subsidiary of the KT&G group. It provides detailed information on company structure, financial status, board composition, shareholding, and internal transactions. This type of regulatory filing is a mandatory disclosure in South Korea for large business groups to report their status to the Fair Trade Commission. Since it is a formal regulatory disclosure document and does not fit into specific categories like 10-K or Earnings Release, it is classified as a Regulatory Filing (RNS).
2022-05-30 Korean
분기보고서 (2022.03)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for the period ending March 31, 2022, for Yungjin Pharm. Co., Ltd. It contains detailed financial statements, business operations, management analysis, and governance information. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). Q1 2022
2022-05-16 Korean
영업(잠정)실적(공정공시)
Earnings Release Classification · 100% confidence The document is a 'Provisional Earnings Report' (영업(잠정)실적) for the first quarter of 2022. It provides key financial highlights such as revenue, operating profit, and net income, comparing them to previous periods. This fits the definition of an Earnings Release (ER), which is an initial announcement of quarterly financial results containing key highlights. Q1 2022
2022-05-10 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an official report of the results of a General Meeting of Shareholders (정기주주총회결과) for the company Youngjin Pharm. It details the approval of financial statements, dividend decisions, and the election of directors and audit committee members. This falls under the category of Declaration of Voting Results & Voting Rights Announcements (DVA), as it provides the official outcome of shareholder votes held at the AGM.
2022-03-24 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 100% confidence The document is a formal regulatory filing titled '사외이사의 선임ㆍ해임 또는 중도퇴임에 관한 신고' (Report on the Appointment, Dismissal, or Resignation of Outside Directors). It details the changes in the board of directors, specifically regarding outside directors, for Yungjin Pharm. This falls directly under the category of Board/Management Information (MANG) as it pertains to changes in the company's board composition.
2022-03-24 Korean
대표이사(대표집행임원)변경(안내공시)
Board/Management Information Classification · 100% confidence The document is a short announcement regarding the change of the company's CEO (Representative Director). It explicitly lists the outgoing and incoming directors, the reason for the change, and the effective date. This fits the definition of a board or management change announcement.
2022-03-24 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.